Evidence map›Paper›PMID 37964321›Full record

ArticleGlobal health research and policy2023

Awareness of and participation in mass drug administration programs used for onchocerciasis control in the Atwima Nwabiagya North District, Ghana.

Francis Adjei Osei, Sam Kofi Tekyi Newton, Isaac Nyanor, Eugene Osei-Yeboah, Evans Xorse Amuzu, Nicholas Karikari Mensah, Obed Ofori Nyarko, Ernest Amanor, Samuel Frimpong Odoom, Suraj Yawnumah Abubakar and 7 more

Open access · diamondAbstract read
In one paragraph

Article in Global health research and policy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Francis Adjei OseiDepartment of Global Health, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. francisph1@hotmail.com.ORCID 0000-0003-1094-813X
Sam Kofi Tekyi NewtonDepartment of Global Health, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Isaac NyanorKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Eugene Osei-YeboahGhana Health Service, Bolgatanga, Ghana.
Evans Xorse AmuzuKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Nicholas Karikari MensahKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Obed Ofori NyarkoKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Ernest AmanorKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Samuel Frimpong OdoomKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Suraj Yawnumah AbubakarKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Mathias DongyeleDepartment of Global Health, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Aliyu MohammedDepartment of Epidemiology and Biostatistics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Ofeibea AsareCareer Development Centre, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Stephanie BoadiKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Peter FuruDepartment of Public Health, Global Health Section, University of Copenhagen, Copenhagen, Denmark.
Dan Wolf MeyrowitschDepartment of Public Health, Global Health Section, University of Copenhagen, Copenhagen, Denmark.
Ellis Owusu-DaboDepartment of Global Health, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Komfo Anokye Teaching Hospital · GHKwame Nkrumah University of Science and Technology · GHUniversity of Copenhagen · DKGhana Health Service · GH

Funding

Danish International Development Agency BSU 3-KNUST
6 · The paper itself

Abstract

backgroundStudies on Mass drug administration (MDA) in Ghana targeting various diseases, have mostly focused on factors that affect coverage and compliance to MDA with limited focus on evidence regarding awareness and community perception of the program. Therefore, this study sought to provide empirical evidence on the knowledge of onchocerciasis, and awareness of and participation in the MDA among community members.

methodsA community-based cross-sectional survey was conducted from August to October 2019 in communities within the Atwima Nwabiagya North District, Ghana. Data was collected from 2,008 respondents. Bivariate and multivariate logistic regression analyses were performed to measure the associations between socio-demographics, having heard of onchocerciasis and its prevention, and levels of awareness of the MDA program.

resultsA total of 1268 respondents (63.2%) were aware of the MDA program. The majority ofMost respondents (74.4%) were of the view that the information given about the program was not enough and 45.4% of the respondents had no idea about the relevance of the MDA program. Respondents who had ever heard about onchocerciasis prevention and persons who had previously participated in the MDA program were more likely to be aware of the MDA program during implementation (AOR = 2.32; 95% CI 1.79-3.01 and AOR = 9.31; 95% CI 7.06-12.26, respectively).

conclusionsWe observed a significant association between being aware of MDA campaigns and knowledge of onchocerciasis and its preventive methods, and participation in previous MDA campaigns. We recommend intensification and improvement of prevention campaigns regarding the onchocerciasis MDA program as key to ensuring increased MDA program participation.

Indexed as

OnchocerciasisCross-Sectional StudiesGhanaHealth Knowledge, Attitudes, PracticeHumansMass Drug AdministrationAwarenessGhanaMass drug administrationOnchocerciasis

Identifiers

PMID37964321
PMCPMC10644529
OpenAlexW4388657614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.